Cover Story
Guest Editorial
As the world faced the threat of a novel respiratory pathogen, SARS-CoV-2, in the first months of 2020, there was a great deal of uncertainty about its effect on people, especially those living with a diagnosis of cancer.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Radiation oncologist, global health expert C. Norman Coleman dies of sarcoma at 79
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Kathy Giusti’s “Fatal to Fearless” memoir tells the story of prevailing over multiple myeloma
Book offers 12 steps to beating cancer in a broken medical system - Population scientist Monica Baskin is the “Jackie Robinson” of cancer center deputy directors
- Biden’s State of the Union highlights healthcare wins in cancer
White House announces ARPA-H precision cancer therapy program and patient navigation commitments - CMS starts paying for patient navigation; ACS offers navigation credentialing program